Trial Profile
A Randomized, Placebo-Controlled Phase II Trial Evaluating Safety and Efficacy of Oral Human Immunoglobulin in the Treatment of Gastrointestinal Dysfunction Associated With Autistic Disorder in Pediatric Patients From 2 to 18 Years of Age.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 Jan 2017
Price :
$35
*
At a glance
- Drugs Immune globulin (Primary)
- Indications Gastrointestinal disorders
- Focus Therapeutic Use
- Sponsors PediaMed Pharmaceuticals
- 30 Dec 2010 New trial record